Marinol (dronabinol) from Schedule II to Schedule III

The DEA is transferring Marinol (dronabinol) from Schedule II to Schedule III.

This will make it easier for patients to get synthetic THC for nausea and vomiting from chemotherapy...or for anorexia and weight loss associated with AIDS.

Marinol has a low abuse potential...probably due to its slow onset. It doesn't produce a quick "high" like marijuana.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote